0001209191-20-026618.txt : 20200501
0001209191-20-026618.hdr.sgml : 20200501
20200501180015
ACCESSION NUMBER: 0001209191-20-026618
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200429
FILED AS OF DATE: 20200501
DATE AS OF CHANGE: 20200501
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YANG MICHAEL J.
CENTRAL INDEX KEY: 0001702283
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 20842132
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 3611 VALLEY CENTRE DRIVE,SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-29
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001702283
YANG MICHAEL J.
C/O ACADIA PHARMACEUTICALS INC.
3611 VALLEY CENTRE DRIVE, STE. 300
SAN DIEGO
CA
92130
0
1
0
0
EVP and CCO
Common Stock
2020-04-29
4
M
0
4206
A
6705
D
Common Stock
2020-04-30
4
S
0
1501
49.21
D
5204
D
Restricted Stock Units
2020-04-29
4
M
0
4206
0.00
D
Common Stock
4206
12621
D
Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
The restricted stock units vest in four equal annual installments beginning 4/29/2020.
/s/ Austin D. Kim, Attorney-in-Fact
2020-05-01